ANXA2 and esophageal squamous cell carcinoma: In conclusion, our study revealed the mechanism of ANXA2/TTK/Akt/mTOR axis in the progression of ESCC, indicating that ANXA2 and TTK may serve as valuable biomarkers and therapeutic targets for ESCC.